Agenda
THURSDAY, MARCH 27, 2025
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dennis Purcell, Founder, Aisling Capital | Former Head of Healthcare Banking JP Morgan / H&Q. Topic: Where Do We Go From Here?
9:40am // Corporate Presentation - Imagion Biosystems (ASX:IBX)
9:55am // Corporate Presentation - CARTx Therapeutics
10:10am // Corporate Presentation - HBC Immunology
10:25am // Corporate Presentation - Amorphical
10:40am // Corporate Presentation - Frantz Viral Therapeutics
10:55am // Corporate Presentation - Aegle Therapeutics Corp
11:10am // Corporate Presentation - Alphyn Biologics
11:25am // Corporate Presentation - Pilatus Biosciences
11:40am // Corporate Presentation - Dioseve
11:55am // Corporate Presentation - PureIMS
12:10pm // Corporate Presentation - Blue Earth Therapeutics
12:25pm // Corporate Presentation - Immunophotonics
12:40pm // LUNCH BREAK
12:55pm // INVESTOR PANEL - Moderator: Bill Werkmeister, MedInvest Conferences. Panelists: Ario Arabi, Executive Director, Global Business Development and Licensing, Novartis; Allen Gobbs, Founder, ATEM Capital; Dr. Themasap Khan, Founder and Partner, Luma Group; Richard Lipkin, Founder, Catalytic Impact Foundation and Parter, Easton Capital; James Schneider, Partner, Cooley
1:35pm // NETWORKING BREAK
1:50pm // Corporate Presentation - Bexion Pharmaceuticals
2:05pm // Corporate Presentation - Teclison
2:20pm // Corporate Presentation - Drusolv Therapeutics
2:35pm // Corporate Presentation - Quiver Bioscience
2:50pm // Corporate Presentation - Kopra Bio
3:05pm // Corporate Presentation - Lemonex
3:20pm // Corporate Presentation - Episteme Prognostics
3:35pm // Corporate Presentation - SciTech Development
3:50pm // Corporate Presentation - Wholomics
4:05pm // Corporate Presentation - Ternalys Therapeutics
4:20pm // Corporate Presentation - Negev Labs
4:35pm // Corporate Presentation - Rakuten Medical
4:50pm // Corporate Presentation - BioAegis Therapeutics
5:05pm // ONCOLOGY PANEL - Moderator: David Schaffer. Panelists: Dr. Ralph Parchment, Co-Founder, SciTech Development | Former Director of Pharmacology at the Karmanos Cancer Institute; Dr. Alfred Slanetz, Chairman, National Foundation for Cancer Research | Former CEO, Bluebird Bio | Former Director of New Product Development, Genetech; Jim Beach, CEO, Bexion Pharmaceuticals
5:45pm // SPEAKER - James Schneider, Partner, Cooley. TOPIC: Transaction - Structure of Life Science Financings
6:05pm // CLOSING REMARKS
6:10pm // RECEPTION
FRIDAY, MARCH 28, 2025
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dr. Alfred Slanetz, Chairman, National Foundation for Cancer Research | Former CEO, Bluebird Bio | Former Director of New Product Development, Genetech. Topic: Advances in Cellular Therapies
9:40am // Corporate Presentation - Processa Pharmaceuticals (PCSA)
9:55am // Corporate Presentation - Chariot Biosciences
10:10am // Corporate Presentation - Angiex
10:25am // Corporate Presentation - Combat Medical
10:40am // Corporate Presentation - RNA NanoBiotics
10:55am // Corporate Presentation - Variational AI
11:10am // Corporate Presentation - PredxBio
11:25am // Corporate Presentation - Baylink Biosciences
11:40am // Corporate Presentation - Ordaos
11:55am // Corporate Presentation - Cell BioEngines
12:10pm // Corporate Presentation - Apricity Health
12:25pm // SPEAKERS - Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU), Technology Transfer Center | National Cancer Institute | National Institutes of Health. Steven Ferguson, Special Advisor, NIH Office of Technology Transfer. Topic: Beyond SBIRs: Leveraging the NIH to Improve Pipelines and Bottom Lines
12:55pm // LUNCH BREAK
1:15pm // SPEAKER - Dr. Lynda Chin, Founder and CEO, Apricity Health | Former Chief Innovation Officer for Health, Univ Texas System, Founding Chair of Genomic Medicine, MD Anderson and Former Professor Dana-Farber Cancer Institute & Harvard Medical School. Topic: AI and Oncology
1:35pm // Corporate Presentation - Interactome Biotherapeutics
1:50pm // Corporate Presentation - OncoXome
2:05pm // Corporate Presentation - Mercury Bio
2:20pm // Corporate Presentation - Cirius Therapeutics
2:35pm // Corporate Presentation - Modra Pharmaceuticals
2:50pm // Corporate Presentation - Geneius Biotechnology
3:05pm // FAMILY OFFICE PANEL DISCUSSION. Moderator: Bill Werkmeister, MedInvest Conferences. Panelists: Alex Kruszewski, Chief Investment Officer, Goldfinch Family Office; Sergei Petukhov, Founder, Ludicrous Ventures; Steven Abernathy, CEO, The Abernathy Group Family Office
3:45pm // CLOSING REMARKS
3:55pm // RECEPTION